Journal of Craniofacial Surgery

Skip Navigation LinksHome > March/April 2002 - Volume 13 - Issue 2 > Tissue-Engineered Bone Using Mesenchymal Stem Cells and a Bi...
Journal of Craniofacial Surgery:
Scientific Foundations

Tissue-Engineered Bone Using Mesenchymal Stem Cells and a Biodegradable Scaffold

Boo, Jae Seong DDS*; Yamada, Yoichi DDS, PhD*; Okazaki, Yasuhiro DDS, PhD*; Hibino, Yoshitaka DDS, PhD†; Okada, Kunihiko PhD†; Hata, Ken-Ichiro DDS, PhD†; Yoshikawa, Takafumi MD, PhD‡; Sugiura, Yasuo MD, PhD§; Ueda, Minoru DDS, PhD*

Collapse Box


Bone marrow has been shown to contain a population of rare cells capable of differentiating to the cells that form various tissues. These cells, referred to as mesenchymal stem cells (MSCs), are capable of forming bone when implanted ectopically in an appropriate scaffold. The aim of this study was to investigate the potential of a new β-tricalcium phosphate (β-TCP) as a scaffold and to compare the osteogenic potential between β-TCP and hydroxyapatite (HA). The β-TCP and HA loaded with MSCs were implanted in subcutaneous sites and harvested at 1, 2, 4, and 8 weeks after implantation for biochemical and histological analysis. Biochemically, in both β-TCP and HA composites, the alkaline phosphatase activity in the composites could be detected and was maintained at a high level for 8 weeks. In the histological analysis, active bone formation could be found in both the β-TCP and HA composites. These findings suggest that β-TCP could play a role as a scaffold as well as HA. The fabricated synthetic bone using biodegradable β-TCP as a scaffold in vivo is useful for reconstructing bone, because the scaffold material is absorbed several months after implantation.

© 2002 Mutaz B. Habal, MD

Follow Us!


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.